Pascal Meier, MD

Commentary
Defining the Optimal Treatment for Elderly Patients: Lessons from Real-World Data
07/13/2009
The elderly and the very elderly are the most rapidly growing segment of the population in the Western world.1–3 The prevalence of coronary artery disease rises with age, and coronary revascularization is commonly performed in elderly...
The elderly and the very elderly are the most rapidly growing segment of the population in the Western world.1–3 The prevalence of coronary artery disease rises with age, and coronary revascularization is commonly performed in elderly...
The elderly and the very elderly...
07/13/2009
Journal of Invasive Cardiology
Commentary
Drug-Eluting Versus Bare-Metal Stents — A One-Horse Race?
01/07/2010
The fact that we are still debating the utility of the bare metal stent (BMS) in 2009 would have seemed unthinkable when the first drug-eluting stent (DES) was approved by the Food and Drug Administration for clinical use in the U.S. in 2003....
The fact that we are still debating the utility of the bare metal stent (BMS) in 2009 would have seemed unthinkable when the first drug-eluting stent (DES) was approved by the Food and Drug Administration for clinical use in the U.S. in 2003....
The fact that we are still...
01/07/2010
Journal of Invasive Cardiology
Commentary
Anticoagulation during Percutaneous Coronary Intervention in Diabetics — Is Simpler Always Better?
02/24/2010
Bivalirudin is theoretically a promising alternative to unfractionated heparin (UFH). It is a direct thrombin inhibitor and has the ability to block circulating and clot-bound thrombin and prevent thrombin-mediated platelet activation.1...
Bivalirudin is theoretically a promising alternative to unfractionated heparin (UFH). It is a direct thrombin inhibitor and has the ability to block circulating and clot-bound thrombin and prevent thrombin-mediated platelet activation.1...
Bivalirudin is theoretically a...
02/24/2010
Journal of Invasive Cardiology
Case Report
The Sword of Damocles: An Illustrative Example of the Life-Saving Effect of the Collateral Circulation
03/01/2011
ABSTRACT: There is an ongoing debate on the effective importance of the collateral network, especially in the current era, where most patients with significant coronary artery disease are revascularized, be it percutaneously or surgically;...
ABSTRACT: There is an ongoing debate on the effective importance of the collateral network, especially in the current era, where most patients with significant coronary artery disease are revascularized, be it percutaneously or surgically;...
ABSTRACT: There is an ongoing...
03/01/2011
Journal of Invasive Cardiology
Original Contribution
Endothelialization of Sirolimus-Eluting Stents with Slow and Extended Drug Release in the Porcine Overstretch Model
12/01/2008
ABSTRACT: Background. Vascular healing of intracoronary stents has been shown to be delayed in drug-eluting stents (DES) due to the cytotoxic compounds on the stent surface that prevent stent ingrowth and endothelialization. The lack of...
ABSTRACT: Background. Vascular healing of intracoronary stents has been shown to be delayed in drug-eluting stents (DES) due to the cytotoxic compounds on the stent surface that prevent stent ingrowth and endothelialization. The lack of...
ABSTRACT: Background. Vascular...
12/01/2008
Journal of Invasive Cardiology
Original Contribution
Endothelial-Cell-Binding Aptamer for Coating of Intracoronary Stents
10/07/2010
ABSTRACT: Oligonucleotides capturing CD31 endothelial cells (= aptamer) were used for coating of intracoronary stents to improve endothelialization and vascular healing. Methods. Three different coronary stents were implanted in 9 farm-raised...
ABSTRACT: Oligonucleotides capturing CD31 endothelial cells (= aptamer) were used for coating of intracoronary stents to improve endothelialization and vascular healing. Methods. Three different coronary stents were implanted in 9 farm-raised...
ABSTRACT: Oligonucleotides...
10/07/2010
Journal of Invasive Cardiology

Upcoming Events

February 2 ⁠–⁠ February 5
LLM Winter Symposium
February 7 ⁠–⁠ February 9
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
GD Solid Tumors
March 22 ⁠–⁠ March 23
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
WoundCon
May 1 ⁠–⁠ May 3
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use